The FDA's Category 2 Bulk Substances List, Explained
Updated 2026-09-02
What the FDA's Category 2 list of bulk drug substances means for compounding pharmacies, and why several popular peptides are on it.
The short answer
The FDA's Category 2 list identifies bulk drug substances that the agency has evaluated and determined present significant safety risks for use in compounding. Substances on this list are generally not permitted for compounding by 503A pharmacies or 503B outsourcing facilities, which is a major reason several peptides that are popular in online discussion, such as BPC-157, are difficult to source from a licensed US pharmacy.
Why this comes up
Readers researching a specific peptide often find that a compounding pharmacy will not prepare it, or that an online seller operates outside any pharmacy license at all. The Category 2 list is usually the reason for the first situation, and understanding it clarifies why a substance can be widely discussed online while remaining unavailable through a licensed, regulated channel in the United States.
What the research and guidance actually say
Compounding in the US is governed primarily by the Drug Quality and Security Act, which
created two pharmacy types with different oversight: 503A pharmacies, which typically
compound for individual patients with a prescription, and 503B outsourcing facilities,
which can compound in larger batches under closer FDA oversight (see
/regulation/503a-vs-503b-compounding-explained/). Both types are restricted in which
"bulk drug substances" they may use. The FDA sorts nominated substances into categories,
and Category 2 substances are those the agency's review found to carry safety concerns
significant enough to generally exclude them from compounding, based on input from its
Pharmacy Compounding Advisory Committee and its own internal safety and effectiveness
assessment process. The list is not static: substances can be added, and in principle
substances can be reassessed, as new safety or effectiveness data is submitted and
reviewed. Because the list updates periodically, any specific list of named substances
in an article can go out of date; the FDA's own published list is the source of record,
and this site's /regulation/fda-compounding-rulings-2026-update/ page tracks the most
recent changes reflected here.
Common misconceptions
Category 2 status means a substance is a controlled drug. Compounding categories under the FDCA and DEA drug scheduling are separate legal frameworks; a substance can be Category 2 without being a scheduled controlled substance, or vice versa.
A pharmacy offering it must be operating legally. A pharmacy or seller offering a Category 2 substance for compounding is a warning sign, not a sign of special access; readers researching a specific pharmacy should verify its license status independently.
The list never changes, so an old article is still accurate. The FDA periodically updates its bulk substance categorizations. Always check the agency's current published list before relying on any single date-stamped source, including this article, as final.
What to ask before you decide
- Is the specific substance I am researching currently listed as Category 1, 2, or unreviewed on the FDA's published list?
- Is the pharmacy or facility offering it licensed as 503A or 503B, and can that be verified with the relevant state board?
- Has the FDA issued any warning letters connected to this substance or this pharmacy?
- What does my state's compounding and telehealth prescribing rule say about this
substance specifically? (See
/regulation/state pages.)
FAQ
What does Category 2 actually mean? It is the FDA's designation for bulk substances nominated for use in compounding that the agency determined present significant safety risks, based on a review by its Pharmacy Compounding Advisory Committee and its own safety assessment.
Does Category 2 mean a substance is illegal to possess? Not automatically. It means the FDA has told 503A and 503B compounders they generally should not use it in compounded preparations. Possession and other legal questions depend on separate laws and, for some substances, DEA scheduling.
Which peptides are on the Category 2 list? BPC-157 is a widely cited example. The list is periodically updated, so always check the FDA's current published list rather than relying on any single article, including this one.
Can a Category 2 substance ever move to a different category? Yes. The FDA periodically reassesses nominated substances as more safety and effectiveness data becomes available, so classifications can change over time.
Sources
- FDA, "FDA Issues List of Bulk Drug Substances Outsourcing Facilities May Use to Compound Under Section 503B" -- https://www.fda.gov/drugs/human-drug-compounding/fda-issues-list-bulk-drug-substances-outsourcing-facilities-may-use-compound-under-section-503b
- FDA, "Drugs Compounded and the Federal Food, Drug, and Cosmetic Act" -- https://www.fda.gov/drugs/human-drug-compounding/drugs-compounded-and-federal-food-drug-and-cosmetic-act
Disclaimer
This content is for general education only and is not medical advice, diagnosis, or treatment. Peptide Briefs does not sell peptides and does not recommend any specific product, dose, or protocol. These statements have not been evaluated by the Food and Drug Administration. Always talk with a licensed healthcare provider before starting, stopping, or changing any therapy.